Enanta Pharmaceuticals Inc.
ENTA | NASDAQ
$12.11
-$0.09 (-0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$12.11
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $352.14M
Enterprise Value $218.29M
Beta 0.94
Average Volume 216.7K
Shares Outstanding (Diluted) 29.09M
Shares Change YoY 36.43%
Institutional Ownership 92.19%
Exchange NASDAQ
ISIN US29251M1062
Price Performance
Price Change 1M -8.7%
Price Change 3M -13.9%
Price Change 6M -0.5%
Price Change YTD -16.0%
Price Change 1Y 57.3%
Price Change 3Y 1.9%
Price Change 5Y -78.4%
1M CAGR (ann.) -12.1%
1Y CAGR (ann.) 54.5%
5Y CAGR (ann.) -26.7%
All-Time CAGR -2.5%
Valuation
PE Ratio -4.75
Forward PE N/A
PEG Ratio -0.08
Forward PEG 0.57
PS Ratio 5.40
Forward PS 5.50
PB Ratio 3.48
P/FCF Ratio -9.53
P/Adj. FCF Ratio -6.74
P/OCF Ratio -10.01
EV/Sales 3.35
EV/EBIT -4.35
EV/EBITDA -4.70
EV/FCF -5.91
Earnings Yield -21.1%
FCF Yield -10.5%
Adj. FCF Yield -14.8%
Financial Health
Net Cash $133.85M
Total Debt $55.66M
Cash & Short-Term Investments $189.51M
Total Assets $296.87M
Current Ratio 3.76
Quick Ratio 3.76
Debt / Equity Ratio 0.55
Debt / EBITDA -1.20
Debt / FCF -1.51
OCF / Debt -0.63
Interest Coverage -4.55
Altman Z-Score -0.77
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 98.2%
Operating Profit Margin -90.0%
EBITDA Margin -71.2%
Net Profit Margin -96.9%
FCF Margin -56.6%
Adj. FCF Margin -80.0%
SBC / Revenue 23.4%
SBC Impact (per share) -41.3%
Returns
Return on Assets -21.3%
Return on Equity -61.8%
Return on Invested Capital -23.8%
Return on Capital Employed -24.2%
Return on Tangible Assets -21.3%
Historical Growth (CAGR)
Revenue CAGR 3Y -6.8%
Revenue CAGR 5Y -7.7%
Revenue CAGR 10Y -3.1%
EPS CAGR 3Y 35.3%
EPS CAGR 5Y 17.6%
EPS CAGR 10Y -36.4%
FCF CAGR 3Y 52.6%
FCF CAGR 5Y 22.6%
FCF CAGR 10Y -49.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 19
EPS Growth Next 3Y 6.3%
Revenue Growth Next 3Y 14.0%
Earnings Date Nov 15, 2026
EPS Estimate (next Q) -$0.77
EPS Growth Est (next Q) -11.5%
Revenue Est (next Q) $15.7M
Revenue Growth Est (next Q) 3.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $20
Price Target Upside 65.2%
Cash Flow
Operating Cash Flow $-35.32M
Free Cash Flow $-36.94M
Adj. Free Cash Flow $-52.21M
FCF Per Share -$1.27
OCF Per Share -$1.21
OCF/S Ratio -54.1%
Income Statement
Revenue $65.26M
Gross Profit $64.05M
Operating Income $-58.73M
EBITDA $-46.49M
Net Income $-63.23M
EPS (Diluted) -$2.55
Revenue / Employee $543.82K
Profit / Employee $-526.92K
Employees 120
Add to Watchlist
Select watchlists to add or remove ENTA